Asieris Pharmaceuticals
- Total Funding$135.3 M
OverviewSuggest Edit
Asieris Pharmaceuticals is a biotech company that specializes in the development and commercialization of pharmaceutical drugs. It aims to provide treatment for genitourinary tumors and related diseases. Asieris has research and development platforms for anti-tumor and anti-microbial resistance drugs.
| Type | Private | |
| Founded | 2010 | |
| HQ | Shanghai, CN | Map |
| Website | asieris.cn |
Latest Updates
| Employees (est.) (Aug 2022) | 41 | (-2%) |
| Cybersecurity rating | A | More |
Asieris Pharmaceuticals Office Locations
Asieris Pharmaceuticals has offices in Shanghai and Wayne
Shanghai, CN (HQ)
8F Building, 1000 Jinhai Rd, Pudong Xinqu
Wayne, PA, US
201 King of Prussia Rd #650
Asieris Pharmaceuticals Financials and Metrics
Summary Metrics
Founding Date | 2010 |
Asieris Pharmaceuticals total Funding | $135.3 m |
Asieris Pharmaceuticals latest funding size | $106 m |
Time since last funding | 2 years ago |
Asieris Pharmaceuticals investors | Qiming Venture Partners, Kaitai Capital, Yanyuan Capital, Lapam Capital, Zhongguancun Qihang Industry Fund, Phoenix Fund |
Asieris Pharmaceuticals's latest funding round in November 2020 was reported to be $106 m. In total, Asieris Pharmaceuticals has raised $135.3 m
Asieris Pharmaceuticals Cybersecurity Score
Asieris Pharmaceuticals Online and Social Media Presence
Asieris Pharmaceuticals's Trends
Asieris Pharmaceuticals News and Updates
April 14, 2022
Asieris Pharmaceuticals Announces 2021 Annual Report: Steady Progress in Core Product Pipeline and Progressive Implementation of the Integrated Diagnosis and Treatment Commercialization Strategy
SHANGHAI, April 14, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176.SH), a global innovative pharmaceutical company specializing in the treatment of genitourinary cancers and related major diseases, announced its 2021 annual report today. The company is currently making steady...
November 11, 2020
China’s Asieris Pharmaceuticals Bags Over $106m Funding Led by Qiming
Genitourinary tumor therapy developer Asieris Pharmaceuticals has closed a Series D round of financing raising over 700 million yuan ($106 million) led by Chinese global venture capital firm Qiming Venture Partners, according to a company statement on Wednesday
Asieris Pharmaceuticals Frequently Asked Questions
When was Asieris Pharmaceuticals founded?
Asieris Pharmaceuticals was founded in 2010.
How many employees does Asieris Pharmaceuticals have?
Asieris Pharmaceuticals has 41 employees.
Who are Asieris Pharmaceuticals competitors?
Competitors of Asieris Pharmaceuticals include The Searle Company, Bio Farma and Relay Therapeutics.
Where is Asieris Pharmaceuticals headquarters?
Asieris Pharmaceuticals headquarters is located at 8F Building, 1000 Jinhai Rd, Pudong Xinqu, Shanghai.
Where are Asieris Pharmaceuticals offices?
Asieris Pharmaceuticals has offices in Shanghai and Wayne.
How many offices does Asieris Pharmaceuticals have?
Asieris Pharmaceuticals has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies